Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.